{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:46:47Z","timestamp":1785880007955,"version":"3.56.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,12]],"date-time":"2027-06-12T00:00:00Z","timestamp":1812758400000},"content-version":"am","delay-in-days":407,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS111767"],"award-info":[{"award-number":["NS111767"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008211","name":"Drexel University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"PhRMA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.molpha.2026.100122","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:04:06Z","timestamp":1776726246000},"page":"100122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and molecular determinants of glutamate transporter allosteric modulators"],"prefix":"10.1016","volume":"108","author":[{"given":"Katelyn L.","family":"Reeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8032-6861","authenticated-orcid":false,"given":"Satyaki","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1783-5482","authenticated-orcid":false,"given":"Xiaowei","family":"Bogetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi N.R.","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Salvino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Hongying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-8239","authenticated-orcid":false,"given":"Ole V.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivet","family":"Bahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-8746","authenticated-orcid":false,"given":"Andr\u00e9ia C.K.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.molpha.2026.100122_bib1","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00018-018-3002-x","article-title":"The dual face of glutamate: from a neurotoxin to a potential survival factor-metabolic implications in health and disease","volume":"76","author":"Magi","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.molpha.2026.100122_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2014.10.008","article-title":"Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities","volume":"20","author":"Jensen","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"22","key":"10.1016\/j.molpha.2026.100122_bib3","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.3390\/ijms20225674","article-title":"Excitatory amino acid transporters (EAATs): glutamate transport and beyond","volume":"20","author":"Magi","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6403","key":"10.1016\/j.molpha.2026.100122_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/360464a0","article-title":"Cloning and expression of a rat brain L-glutamate transporter","volume":"360","author":"Pines","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2026.100122_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1471-4159.2003.01553.x","article-title":"The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings","volume":"84","author":"Suchak","year":"2003","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.molpha.2026.100122_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.20003","article-title":"Altered expression of the glutamate transporter EAAT2b in neurological disease","volume":"55","author":"Maragakis","year":"2004","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.molpha.2026.100122_bib7","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.molpha.2026.100122_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neuroscience.2014.07.019","article-title":"Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study","volume":"277","author":"Roberts","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.molpha.2026.100122_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.670346","article-title":"Regulation of glutamate, GABA and dopamine transporter uptake, surface mobility and expression","volume":"15","author":"Ryan","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11064-021-03252-x","article-title":"Molecular basis of coupled transport and anion conduction in excitatory amino acid transporters","volume":"47","author":"Alleva","year":"2022","journal-title":"Neurochem Res"},{"issue":"48","key":"10.1016\/j.molpha.2026.100122_bib11","doi-asserted-by":"crossref","first-page":"28988","DOI":"10.1074\/jbc.M115.682666","article-title":"Molecular Determinants of Substrate Specificity in Sodium-coupled Glutamate Transporters","volume":"290","author":"Silverstein","year":"2015","journal-title":"J Biol Chem"},{"issue":"7651","key":"10.1016\/j.molpha.2026.100122_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22064","article-title":"Structure and allosteric inhibition of excitatory amino acid transporter 1","volume":"544","author":"Canul-Tec","year":"2017","journal-title":"Nature"},{"issue":"7275","key":"10.1016\/j.molpha.2026.100122_bib13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature08616","article-title":"Transport mechanism of a bacterial homologue of glutamate transporters","volume":"462","author":"Reyes","year":"2009","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.molpha.2026.100122_bib14","doi-asserted-by":"crossref","DOI":"10.1063\/5.0046710","article-title":"Normal mode analysis of membrane protein dynamics using the vibrational subsystem analysis","volume":"154","author":"Zhang","year":"2021","journal-title":"J Chem Phys"},{"issue":"6","key":"10.1016\/j.molpha.2026.100122_bib15","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.bpj.2012.02.028","article-title":"Constraints imposed by the membrane selectively guide the alternating access dynamics of the glutamate transporter GltPh","volume":"102","author":"Lezon","year":"2012","journal-title":"Biophys J"},{"issue":"37","key":"10.1016\/j.molpha.2026.100122_bib16","doi-asserted-by":"crossref","first-page":"15141","DOI":"10.1073\/pnas.1112216108","article-title":"Large collective motions regulate the functional properties of glutamate transporter trimers","volume":"108","author":"Jiang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.molpha.2026.100122_bib17","doi-asserted-by":"crossref","first-page":"28680","DOI":"10.1074\/jbc.M800889200","article-title":"Time-resolved mechanism of extracellular gate opening and substrate binding in a glutamate transporter","volume":"283","author":"Shrivastava","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2026.100122_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2020.00051","article-title":"Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells","volume":"14","author":"Belov Kirdajova","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"10.1016\/j.molpha.2026.100122_bib19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ijnp\/pyx050","article-title":"Glutamate transport: a new bench to bedside mechanism for treating drug abuse","volume":"20","author":"Spencer","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.molpha.2026.100122_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106492","article-title":"Glutamatergic systems in neuropathic pain and emerging non-opioid therapies","volume":"185","author":"Temmermand","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.molpha.2026.100122_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114786","article-title":"Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development","volume":"193","author":"Green","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.molpha.2026.100122_bib22","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/acschemneuro.9b00061","article-title":"Novel positive allosteric modulators of glutamate transport have neuroprotective properties in an in vitro excitotoxic model","volume":"10","author":"Falcucci","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.molpha.2026.100122_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1021\/acschemneuro.7b00308","article-title":"Identification of novel allosteric modulators of glutamate transporter EAAT2","volume":"9","author":"Kortagere","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"11","key":"10.1016\/j.molpha.2026.100122_bib24","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1021\/acschemneuro.0c00007","article-title":"Elucidation of the structure and synthesis of neuroprotective low molecular mass components of the Parawixia bistriata spider venom","volume":"11","author":"Forster","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"10.1016\/j.molpha.2026.100122_bib25","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/sj.bjp.0705352","article-title":"Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake","volume":"139","author":"Fontana","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2026.100122_bib26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1124\/mol.107.037127","article-title":"Enhancing glutamate transport: mechanism of action of Parawixin1, a neuroprotective compound from Parawixia bistriata spider venom","volume":"72","author":"Fontana","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100122_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/jnc.13047","article-title":"Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains","volume":"133","author":"Mortensen","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.molpha.2026.100122_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104792","article-title":"Transport rate of EAAT2 is regulated by amino acid located at the interface between the scaffolding and substrate transport domains","volume":"139","author":"Duffield","year":"2020","journal-title":"Neurochem Int"},{"issue":"7537","key":"10.1016\/j.molpha.2026.100122_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature14158","article-title":"Transport domain unlocking sets the uptake rate of an aspartate transporter","volume":"518","author":"Akyuz","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molpha.2026.100122_bib30","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1021\/acs.jmedchem.3c01909","article-title":"Synthesis and structure-activity relationships for glutamate transporter allosteric modulators","volume":"67","author":"Fontana","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.molpha.2026.100122_bib31","series-title":"National Institute of Mental Health Psychoactive Drug Screening Program (NIMH PDSP). Assay Protocol Book","author":"Roth","year":"2018"},{"issue":"8","key":"10.1016\/j.molpha.2026.100122_bib32","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"9","key":"10.1016\/j.molpha.2026.100122_bib33","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/bioinformatics\/bty816","article-title":"Large-scale prediction of binding affinity in protein-small ligand complexes: the PRODIGY-LIG web server","volume":"35","author":"Vangone","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib34","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/s41467-023-38120-5","article-title":"Symport and antiport mechanisms of human glutamate transporters","volume":"14","author":"Qiu","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","article-title":"GNINA 1.3: the next increment in molecular docking with deep learning","volume":"17","author":"McNutt","year":"2025","journal-title":"J Cheminform"},{"issue":"18","key":"10.1016\/j.molpha.2026.100122_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2418100122","article-title":"Accurate identification and mechanistic evaluation of pathogenic missense variants with Rhapsody-2","volume":"122","author":"Banerjee","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib37","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1038\/s41467-022-32442-6","article-title":"Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2","volume":"13","author":"Kato","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.molpha.2026.100122_bib38","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1523\/JNEUROSCI.14-09-05559.1994","article-title":"Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex","volume":"14","author":"Arriza","year":"1994","journal-title":"J Neurosci"},{"issue":"17","key":"10.1016\/j.molpha.2026.100122_bib39","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1021\/acs.jmedchem.2c00534","article-title":"Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a novel orally bioavailable EAAT2 Modulator with drug-like properties and potent antiseizure activity in vivo","volume":"65","author":"Abram","year":"2022","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib40","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1002\/cpph.45","article-title":"Protocols for measuring glutamate uptake: dose-response and kinetic assays in in vitro and ex vivo systems","volume":"82","author":"Fontana","year":"2018","journal-title":"Curr Protoc Pharmacol"},{"issue":"W1","key":"10.1016\/j.molpha.2026.100122_bib41","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib42","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1038\/s41467-022-31031-x","article-title":"Structural basis of ligand binding modes of human EAAT2","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.molpha.2026.100122_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf5814","article-title":"Cryo-EM structures of excitatory amino acid transporter 3 visualize coupled substrate, sodium, and proton binding and transport","volume":"7","author":"Qiu","year":"2021","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.molpha.2026.100122_bib44","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1074\/jbc.M112.438432","article-title":"Intracellular gating in an inward-facing state of aspartate transporter Glt(Ph) is regulated by the movements of the helical hairpin HP2","volume":"288","author":"Zomot","year":"2013","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108341","article-title":"The ion-coupling mechanism of human excitatory amino acid transporters","volume":"41","author":"Canul-Tec","year":"2022","journal-title":"EMBO J"},{"issue":"7469","key":"10.1016\/j.molpha.2026.100122_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature12265","article-title":"Transport dynamics in a glutamate transporter homologue","volume":"502","author":"Akyuz","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2026.100122_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58417","article-title":"Large domain movements through the lipid bilayer mediate substrate release and inhibition of glutamate transporters","volume":"9","author":"Wang","year":"2020","journal-title":"Elife"},{"issue":"7469","key":"10.1016\/j.molpha.2026.100122_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature12538","article-title":"Unsynchronised subunit motion in single trimeric sodium-coupled aspartate transporters","volume":"502","author":"Erkens","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2026.100122_bib49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cell.2014.12.035","article-title":"Mechanisms of anion conduction by coupled glutamate transporters","volume":"160","author":"Machtens","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2026.100122_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25850","article-title":"Substrate transport and anion permeation proceed through distinct pathways in glutamate transporters","volume":"6","author":"Cheng","year":"2017","journal-title":"Elife"},{"issue":"22","key":"10.1016\/j.molpha.2026.100122_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz1949","article-title":"Single-molecule transport kinetics of a glutamate transporter homolog shows static disorder","volume":"6","author":"Ciftci","year":"2020","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib52","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105415","article-title":"The high-energy transition state of the glutamate transporter homologue GltPh","volume":"40","author":"Huysmans","year":"2021","journal-title":"EMBO J"},{"issue":"49","key":"10.1016\/j.molpha.2026.100122_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025520118","article-title":"Linking function to global and local dynamics in an elevator-type transporter","volume":"118","author":"Ciftci","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.molpha.2026.100122_bib54","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/jcmm.16212","article-title":"Critical amino acids in the TM2 of EAAT2 are essential for membrane-bound localization, substrate binding, transporter function and anion currents","volume":"25","author":"Mai","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.molpha.2026.100122_bib55","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/acschemneuro.3c00731","article-title":"Still in Search for an EAAT activator: GT949 does not activate EAAT2, nor EAAT3 in impedance and radioligand uptake assays","volume":"15","author":"van Veggel","year":"2024","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"10.1016\/j.molpha.2026.100122_bib56","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.1074\/jbc.M114.630590","article-title":"Transport rates of a glutamate transporter homologue are influenced by the lipid bilayer","volume":"290","author":"McIlwain","year":"2015","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.molpha.2026.100122_bib57","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1021\/acs.analchem.6b02984","article-title":"High-throughput lipidomic and transcriptomic analysis to compare SP2\/0, CHO, and HEK-293 mammalian cell lines","volume":"89","author":"Zhang","year":"2017","journal-title":"Anal Chem"},{"issue":"50","key":"10.1016\/j.molpha.2026.100122_bib58","doi-asserted-by":"crossref","first-page":"18275","DOI":"10.1523\/JNEUROSCI.3305-11.2011","article-title":"Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria","volume":"31","author":"Genda","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.molpha.2026.100122_bib59","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014050","article-title":"Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins","volume":"11","author":"Geiger","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"1-3","key":"10.1016\/j.molpha.2026.100122_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2008.06.012","article-title":"Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia","volume":"104","author":"Bauer","year":"2008","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/ijms22010059","article-title":"Glutamatergic dysfunction and synaptic ultrastructural alterations in schizophrenia and autism spectrum disorder: evidence from human and rodent studies","volume":"22","author":"Eltokhi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nyas.12547","article-title":"The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies","volume":"1338","author":"Hu","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.molpha.2026.100122_bib63","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.biopsych.2008.05.001","article-title":"Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2\/3 agonist","volume":"64","author":"Karlsson","year":"2008","journal-title":"Biological psychiatry"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1568026611313010005","article-title":"Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks","volume":"13","author":"Menniti","year":"2013","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"10.1016\/j.molpha.2026.100122_bib65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5498\/wjp.v8.i2.51","article-title":"Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders","volume":"8","author":"Parkin","year":"2018","journal-title":"World J Psychiatry"},{"issue":"2","key":"10.1016\/j.molpha.2026.100122_bib66","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2011.03.022","article-title":"Drug targets for cognitive enhancement in neuropsychiatric disorders","volume":"99","author":"Wallace","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.molpha.2026.100122_bib67","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012433","article-title":"The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes","volume":"13","author":"Scaramuzza","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.molpha.2026.100122_bib68","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/cercor\/bhv002","article-title":"Mechanisms of functional hypoconnectivity in the medial prefrontal cortex of Mecp2 null mice","volume":"26","author":"Sceniak","year":"2016","journal-title":"Cereb Cortex"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"7466","key":"10.1016\/j.molpha.2026.100122_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12439","article-title":"De novo mutations in epileptic encephalopathies","volume":"501","author":"Allen","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molpha.2026.100122_bib71","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ajhg.2017.07.004","article-title":"De Novo mutations in YWHAG cause early-onset epilepsy","volume":"101","author":"Guella","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.molpha.2026.100122_bib72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000172638.58172.5a","article-title":"Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures","volume":"65","author":"Jen","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneurol.2008.535","article-title":"Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake","volume":"66","author":"de Vries","year":"2009","journal-title":"Arch Neurol"},{"issue":"Pt 11","key":"10.1016\/j.molpha.2026.100122_bib74","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1093\/brain\/aws255","article-title":"A point mutation associated with episodic ataxia 6 increases glutamate transporter anion currents","volume":"135","author":"Winter","year":"2012","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.molpha.2026.100122_bib75","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/humu.24089","article-title":"Functional consequences of SLC1A3 mutations associated with episodic ataxia 6","volume":"41","author":"Chivukula","year":"2020","journal-title":"Hum Mutat"},{"issue":"7","key":"10.1016\/j.molpha.2026.100122_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154891","article-title":"Ataxia-linked SLC1A3 mutations alter EAAT1 chloride channel activity and glial regulation of CNS function","volume":"132","author":"Wu","year":"2022","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.molpha.2026.100122_bib77","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/epi.17154","article-title":"Mutations associated with epileptic encephalopathy modify EAAT2 anion channel function","volume":"63","author":"Kovermann","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.molpha.2026.100122_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105648","article-title":"The severity of SLC1A2-associated neurodevelopmental disorders correlates with transporter dysfunction","volume":"114","author":"Kovermann","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.molpha.2026.100122_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa022","article-title":"Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6","volume":"2","author":"Kovermann","year":"2020","journal-title":"Brain Commun"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:05:08Z","timestamp":1785877508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":79,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0026895X26000222"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100122","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural and molecular determinants of glutamate transporter allosteric modulators","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100122"}}